Trademark: 97896217
Word
SUPELLIA
Status
Pending
Status Code
688
Status Date
Tuesday, April 2, 2024
Serial Number
97896217
Mark Type
4000
Filing Date
Wednesday, April 19, 2023
Published for Opposition
Tuesday, February 6, 2024

Trademark Owner History
TEVA PHARMACEUTICALS USA, Inc. - Owner At Publication

Classifications
5 Pharmaceutical preparations, namely, oral and injectable contraceptives, women's hormone replacement medications; pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations

Trademark Events
Apr 2, 2024
Noa E-Mailed - Sou Required From Applicant
Feb 6, 2024
Official Gazette Publication Confirmation E-Mailed
Feb 6, 2024
Published For Opposition
Jan 17, 2024
Notification Of Notice Of Publication E-Mailed
Jan 2, 2024
Approved For Pub - Principal Register
Jan 2, 2024
Assigned To Examiner
May 15, 2023
New Application Office Supplied Data Entered
Apr 22, 2023
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24